Children's cancers, Neuroblastoma
Open
Phase 2
This trial is looking at naxitamab with GM-CSF to treat neuroblastoma that has continued to grow during treatment or has come back afterwards.
The trial is mainly for children and young people. We use the term 'you' in this summary, but if you are a parent, we are referring to your child.
Recruitment start: 1 March 2018
Recruitment end: 31 December 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Juliet Gray
Y-mAbs Therapeutics
Last reviewed: 01 Sept 2025
CRUK internal database number: 18383
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
